Related Experiment Video
Updated: Mar 8, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
28.0K
Overfat and Underfat: New Terms and Definitions Long Overdue
Philip B Maffetone1, Ivan Rivera-Dominguez1, Paul B Laursen2
1MAFF FITNESS PTY LTD. , Sydney , Australia.
Frontiers in Public Health
|January 19, 2017
Summary
The global population faces an "overfat pandemic," exceeding underweight individuals. New terms, "overfat" and "underfat," could improve public health awareness and interventions for abnormal body composition.
Area of Science:
- Public Health
- Human Physiology
- Metabolic Health
Background:
- The global obesity epidemic is well-documented, with obese individuals now outnumbering underweight ones.
- Excess body fat, termed the "overfat" condition, presents a significant health concern, often undetected by traditional metrics like Body Mass Index (BMI).
- The underfat state, characterized by insufficient body fat, is also a prevalent and dangerous health issue, particularly in developing nations where it coexists with rising obesity rates.
Purpose of the Study:
- To introduce and advocate for the terms "overfat" and "underfat" to describe body composition states.
- To suggest that improved terminology can enhance public awareness and facilitate the adoption of preventive measures and remedies for abnormal body fat conditions.
- To propose that widespread adoption of "overfat" and "underfat" terminology could lead to substantial global health improvements.
Main Methods:
- Conceptual analysis drawing on cognitive linguistics to explore the impact of terminology on public perception and behavior.
- Review of existing epidemiological data on obesity, underweight, and body composition.
Main Results:
- The current classification of obesity using BMI may not fully capture the extent of the overfat pandemic.
- The overfat condition, distinct from clinical obesity, is a widespread issue linked to metabolic impairments.
- The underfat condition represents a significant, often overlooked, health risk.
Conclusions:
- The terms "overfat" and "underfat" offer a more accurate and accessible way to describe body composition compared to existing classifications.
- Implementing these terms in common language could significantly improve public understanding and engagement with health issues related to body fat.
- Promoting "overfat" and "underfat" terminology holds the potential to drive positive changes in global health outcomes.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Hypodermis
8.3K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
8.3K
Drug Dosing: Obese Patients
320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
336
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
336
Anorexia Nervosa
1.6K
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259

